
Estrogen Patches with ARPIs Found to Be Safe, Effective in Prostate Cancer
Patients with metastatic prostate cancer showed similar prostate-specific antigen (PSA) responded when treated with transdermal estradiol (tE2) patches and androgen receptor pathway inhibitors (ARPIs), such as Zytiga (abiraterone), Xtandi (enzalutamide) or …